Bristol Gate Capital Partners Inc. increased its position in UnitedHealth Group Inc. (NYSE:UNH) by 6.2% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 206,605 shares of the healthcare conglomerate’s stock after buying an additional 12,133 shares during the period. UnitedHealth Group makes up 5.0% of Bristol Gate Capital Partners Inc.’s portfolio, making the stock its largest position. Bristol Gate Capital Partners Inc.’s holdings in UnitedHealth Group were worth $28,925,000 at the end of the most recent reporting period.

Other hedge funds also recently bought and sold shares of the company. Chevy Chase Trust Holdings Inc. raised its stake in UnitedHealth Group by 2.7% in the second quarter. Chevy Chase Trust Holdings Inc. now owns 1,095,944 shares of the healthcare conglomerate’s stock worth $154,747,000 after buying an additional 28,945 shares during the period. Exxonmobil Investment Management Inc. TX raised its stake in UnitedHealth Group by 6.3% in the second quarter. Exxonmobil Investment Management Inc. TX now owns 246,116 shares of the healthcare conglomerate’s stock worth $34,752,000 after buying an additional 14,650 shares during the period. DNB Asset Management AS raised its stake in UnitedHealth Group by 5.1% in the second quarter. DNB Asset Management AS now owns 573,902 shares of the healthcare conglomerate’s stock worth $81,035,000 after buying an additional 27,800 shares during the period. Daiwa SB Investments Ltd. purchased a new position in UnitedHealth Group during the second quarter worth approximately $6,183,000. Finally, Washington Trust Bank increased its position in UnitedHealth Group by 0.4% in the second quarter. Washington Trust Bank now owns 29,319 shares of the healthcare conglomerate’s stock worth $4,140,000 after buying an additional 109 shares in the last quarter. 84.92% of the stock is owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Shares of UnitedHealth Group Inc. (NYSE:UNH) traded up 3.73% during mid-day trading on Tuesday, hitting $157.79. The stock had a trading volume of 1,616,807 shares. The stock’s 50-day moving average price is $143.81 and its 200 day moving average price is $139.88. UnitedHealth Group Inc. has a 1-year low of $107.51 and a 1-year high of $158.12. The company has a market capitalization of $150.19 billion, a P/E ratio of 23.31 and a beta of 0.63.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, topping analysts’ consensus estimates of $2.08 by $0.09. The business had revenue of $46.30 billion for the quarter, compared to analyst estimates of $46.09 billion. UnitedHealth Group had a return on equity of 19.92% and a net margin of 3.62%. The firm’s revenue was up 11.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.77 EPS. On average, analysts predict that UnitedHealth Group Inc. will post $8.01 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 13th. Shareholders of record on Friday, December 2nd will be issued a $0.625 dividend. This represents a $2.50 dividend on an annualized basis and a yield of 1.64%. The ex-dividend date of this dividend is Wednesday, November 30th. UnitedHealth Group’s dividend payout ratio is 36.93%.

COPYRIGHT VIOLATION WARNING: “UnitedHealth Group Inc. (UNH) Shares Bought by Bristol Gate Capital Partners Inc.” was reported by The Cerbat Gem and is the propert of of The Cerbat Gem. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of US & international trademark and copyright legislation. The original version of this piece of content can be read at https://www.thecerbatgem.com/2016/11/29/unitedhealth-group-inc-unh-shares-bought-by-bristol-gate-capital-partners-inc.html.

A number of research firms recently commented on UNH. Vetr upgraded UnitedHealth Group from a “buy” rating to a “buy” rating in a report on Friday, October 7th. Jefferies Group restated a “buy” rating and issued a $163.00 price objective on shares of UnitedHealth Group in a report on Tuesday, October 4th. Leerink Swann restated an “outperform” rating on shares of UnitedHealth Group in a report on Sunday, August 21st. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday. Finally, Cowen and Company set a $150.00 price objective on UnitedHealth Group and gave the stock a “buy” rating in a report on Tuesday, September 6th. Three analysts have rated the stock with a hold rating and twenty-one have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $158.03.

In other UnitedHealth Group news, Director Gail R. Wilensky sold 5,460 shares of the company’s stock in a transaction on Thursday, November 17th. The stock was sold at an average price of $150.55, for a total value of $822,003.00. Following the transaction, the director now directly owns 60,052 shares of the company’s stock, valued at approximately $9,040,828.60. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Richard T. Burke sold 40,000 shares of the company’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total value of $5,412,400.00. Following the completion of the transaction, the director now directly owns 2,003,550 shares in the company, valued at $271,100,350.50. The disclosure for this sale can be found here. 1.65% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

5 Day Chart for NYSE:UNH

Receive News & Stock Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related stocks with our FREE daily email newsletter.